On December 10, 2021, our multi-site expanded access study site for MDMA-assisted therapy for patients with treatment-resistant PTSD at the Pearl Psychedelic Institute in Waynesville, North Carolina, was activated for phone screening.
Researchers from the MAPS Public Benefit Corporation (MAPS PBC) conducted a site initiation visit for the Expanded Access Program study site at Sage Integrative Health in Berkeley, CA on December 6, 2021.